Janus Henderson Group’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Janus Henderson Group’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-356	Closed	-$5.94M	–	1427
2019 Q4	$5.94M	Sell	356 -38	-10%	-$633K	﹤0.01%	1026
2019 Q3	$6.35M	Sell	394 -8	-2%	-$129K	﹤0.01%	1026
2019 Q2	$8.68M	Sell	402 -3	-0.7%	-$74.2K	﹤0.01%	967
2019 Q1	$11.4M	Sell	405 -44	-10%	-$1.06M	0.01%	896
2018 Q4	$6.66M	Sell	449 -116	-21%	-$2.6M	﹤0.01%	937
2018 Q3	$20M	Sell	565 -1	-0.2%	-$30.9K	0.01%	818
2018 Q2	$16.5M	Sell	566 -2	-0.4%	-$77.7K	0.01%	843
2018 Q1	$76.8M	Buy	+568	New	+$69.1M	0.05%	444

Other funds holding YARW

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group's YARW Position: Q1 2020 in Review

Janus Henderson Group sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2020, closing a stake of 356 shares — an estimated $5.94M sold.

Janus Henderson Group first reported a position in YARW in Q1 2018 and held it in 8 quarters. The position peaked at $76.8M in Q1 2018. 86 funds tracked by Wall St. Rank hold YARW as of Q1 2020.

Janus Henderson Group reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Janus Henderson Group sold 356 Yarrow Bioscience, Inc. Common Stock shares in Q1 2020, an estimated $5.94M.
Janus Henderson Group first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and held it in 8 quarters.
Janus Henderson Group's Yarrow Bioscience, Inc. Common Stock position peaked at $76.8M in Q1 2018.
86 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2020.

Based on Janus Henderson Group's 13F filing for Q1 2020, filed 14 May 2020.